OCUL Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: OCUL Market Cap History OCUL YTD Return |
OCUL Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: OCUL Market Cap History OCUL YTD Return |
OCUL Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+21.81% CAGR ![]() Mouse over chart for data details
|
OCUL Stock Price Chart |
About Ocular Therapeutix Inc |
Ocular Therapeutix, Inc. is a biopharmaceutical company engaged in the development and commercialization therapies for eye conditions, including wet age-related macular degeneration (wet AMD), diabetic retinopathy and other ocular diseases. Co.'s commercial product, DEXTENZA, treats ocular inflammation and pain following eye surgery and ocular itching due to allergic conjunctivitis. Co. is also developing OTX-DED for short-term dry eye disease treatment and OTX-CSI for chronic dry eye disease management. It is conducting a Phase III trial for AXPAXLI to treat wet AMD and are also advancing PAXTRAVA in Phase III clinical development for primary open-angle glaucoma or ocular hypertension. We show 43 historical shares outstanding datapoints in our coverage of OCUL's shares outstanding history. Understanding the changing numbers of OCUL shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like OCUL versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching OCUL by allowing them to research OCUL shares outstanding history as well as any other stock in our coverage universe. |
OCUL Current Stock Quote |
![]() Get Dividend Alerts ![]() Get SEC Filing Alerts ![]() |
Video: Shares Outstanding Importance | |
|
OCUL Share Performance |
Shares Outstanding Peers |
Ocular Therapeutix (OCUL) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
OCUP Shares Outstanding History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.